Drug · DIN 02450240 · Veterinary
NERFASIN 100
MULTIDOSE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 19, 2020; first marketed September 1, 2016.
- Drug Identification Number (DIN)
- 02450240
- Company (DIN owner)
- Dechra Regulatory BvBladel, Netherlands
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intramuscular; Intravenous
- Class
- Veterinary
- Record last updated
- August 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| XYLAZINE (XYLAZINE HYDROCHLORIDE) | 100 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 13, 2019: NOC 22286Abbreviated New Drug Submission (ANDS) · Changes in product wonership
- December 17, 2015: NOC 17585Abbreviated New Drug Submission (ANDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “nerfasin”. A notice may cover another product or only some lots: read it to see what it covers.
- Nerfasin 20 injection; Presence of particlesMay 15, 2023 · Veterinary drugs · Product quality · Type I
- NERFASIN 20: Affected lot may contain the presence of particlesAugust 29, 2022 · Veterinary drugs · Product quality · Type I
- Nerfasin 20: quality issue (presence of particles)November 30, 2021 · Veterinary drugs · Product quality · Type I